These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 576555

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Investigations on the antihypertensive activity of timolol and bendroflumethiazide and the combination in dogs and rats.
    Nielsen KC, Olsen UB, Ronne A, Arrigoni-Martelli E.
    Acta Pharmacol Toxicol (Copenh); 1976; 39(5):500-12. PubMed ID: 990034
    [Abstract] [Full Text] [Related]

  • 3. The renal kallikrein-kinin system in spontaneously hypertensive rats.
    Bönner G, Unger T, Rascher W, Speck G, Ganten D, Gross F.
    Agents Actions; 1984 Oct; 15(3-4):111-8. PubMed ID: 6570082
    [Abstract] [Full Text] [Related]

  • 4. [Renal kallikrein-kinin system and control of blood pressure (author's transl)].
    Distler A, Wolff HP.
    Klin Wochenschr; 1979 Oct 01; 57(19):1037-45. PubMed ID: 392177
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of bumetanide upon PRA and urinary kallikrein excretion in normal subjects before and after indomethacin treatment.
    Pierucci A, Simonetti BM, Stirati G, Cinotti GA.
    Minerva Nefrol; 1980 Oct 01; 27(3):421-4. PubMed ID: 7015179
    [No Abstract] [Full Text] [Related]

  • 8. The supra-additive natriuretic effect addition of bendroflumethiazide and bumetanide in congestive heart failure. Permutation trial tests in patients in long-term treatment with bumetanide.
    Sigurd B, Olesen KH, Wennevold A.
    Am Heart J; 1975 Feb 01; 89(2):163-70. PubMed ID: 1090132
    [Abstract] [Full Text] [Related]

  • 9. Renin-angiotensin and kallikrein-kinin systems in sodium homeostasis and hypertension in rats.
    Johnston CI, Matthews PG, Dax E.
    Clin Sci Mol Med Suppl; 1976 Dec 01; 3():283s-286s. PubMed ID: 1071628
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Selected components of the kallikrein-kinin system and of the renin-angiotensin-aldosterone system in offspring of parents with hypertension].
    Marzecka J.
    Ann Acad Med Stetin; 1996 Dec 01; 42():123-38. PubMed ID: 9199117
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of furosemide on urinary kallikrein excretion in patients with essential hypertension.
    Seino M, Abe K, Irokawa N, Ito T, Yasujima M, Sakurai Y, Chiba S, Saito K, Ritz K, Kusaka T, Miyazaki S, Yoshinaga K.
    Tohoku J Exp Med; 1978 Mar 01; 124(3):197-203. PubMed ID: 635897
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Urinary kallikrein excretion and plasma renin activity in patients with essential hypertension and primary aldosteronism.
    Lechi A, Covi G, Lechi C, Corgnati A, Arosio E, Zatti M, Scuro LA.
    Clin Sci Mol Med; 1978 Jul 01; 55(1):51-5. PubMed ID: 668267
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prostaglandin/kinin activity related to changed renal compliance after bumetanide in dogs.
    Olsen UB.
    Acta Pharmacol Toxicol (Copenh); 1977 Mar 01; 40(3):430-8. PubMed ID: 576566
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.